Today: 17 June 2026
Browse Category

NASDAQ:NUVL 14 January 2026 - 10 June 2026

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
9 June 2026
··

Stock Market Today

  • Stocks Indexes Slip as Chipmakers and Energy Sector Weigh; Dow Hits Record High
    June 17, 2026, 5:11 AM EDT. Stock indexes closed mixed Tuesday with the S&P 500 down 0.57%, Nasdaq 100 off 1.89%, and Dow Jones Industrial Average rising 0.64% to a new all-time high. Chipmakers declined, dragging tech-heavy Nasdaq lower. Energy shares tumbled on a 5% drop in crude oil prices after the US-Iran deal to reopen the Strait of Hormuz, easing supply concerns. U.S. May housing starts fell sharply, hitting a six-year low and raising concerns over the real estate sector. The 10-year Treasury yield fell 5 basis points to 4.42%. Markets now eye the Federal Reserve's two-day meeting under new Chair Kevin Warsh, expecting no rate changes but watchful for forward guidance. Overseas indexes traded mixed, with the Euro Stoxx 50 up 0.45%, China's Shanghai Composite down 0.11%, and Japan's Nikkei reaching a record high.

Latest articles

Our Bond shares edge lower after sharp rally on debt swap, city license updates

Our Bond shares edge lower after sharp rally on debt swap, city license updates

17 June 2026
Our Bond Inc. shares fell 8.1% to $1.02 premarket after a 108.5% surge, as investors digested a $3.3 million debt-for-preferred-equity swap at a $2.0265 conversion price—over 200% above recent levels—and a municipality-funded license deal covering 270,000 residents, with CEO Doron Kempel set to address investors at 11:00 a.m. ET.
AST SpaceMobile Drops Premarket After SpaceX BlueBird 8-10 Launch

AST SpaceMobile Drops Premarket After SpaceX BlueBird 8-10 Launch

17 June 2026
AST SpaceMobile shares dropped about 6% to $82.25 in early premarket trading after SpaceX confirmed deployment of three new BlueBird satellites, a key test following April’s costly BlueBird 7 loss; investors face near-term risks around satellite commissioning, regulatory approvals, and execution despite reaffirmed 2026 satellite targets and $150–200 million revenue guidance.
Go toTop